Crosstalk occurs between MAPK pathway and PI3K pathway is one of the reasons that lead to MEK inhibitor resistance [215, 216], and PI3K pathway is another critical signaling pathway in NRAS‐mutant melanoma [65, 66]. The gene discussed is MAP2K7; the disease is melanoma.